Suppr超能文献

穿透性角膜移植术后严重角膜移植排斥反应后角膜移植恢复的预后因素。

Prognostic factors for corneal graft recovery after severe corneal graft rejection following penetrating keratoplasty.

机构信息

Department of Ophthalmology, Tokyo Dental College, 5-11-13 Sugano, Ichikawa, Chiba 272-8513, Japan.

出版信息

BMC Ophthalmol. 2013 Feb 25;13:5. doi: 10.1186/1471-2415-13-5.

Abstract

BACKGROUND

To investigate the outcome and prognostic factors for corneal graft recovery after severe corneal graft rejection following penetrating keratoplasty (PKP) treated with topical and systemic steroids.

METHODS

Fifty-eight eyes in 58 patients with severe corneal graft rejection following PKP were treated with topical and systemic steroids. Factors affecting the reversibility and maintenance of graft transparency were analyzed.

RESULTS

Graft transparency was restored in 37 of 58 eyes (63.8%). Clarity of the graft was maintained in 25 of 37 eyes after transparency was restored, while corneal decompensation developed at a mean of 6.0 ± 4.3 months in the remainder. The interval between rejection and treatment with systemic steroids was shorter in cases that recovered graft transparency (OR, 0.88, 95% CI. 0.80-0.97, P = 0.0093). Corneal decompensation after the recovery of corneal transparency tend to occur in cases of regraft (OR, 0.09, 95% CI. 0.01-0.54, P = 0.0091).

CONCLUSIONS

Severe corneal graft rejection after PKP was reversible in approximately two-thirds of the cases, with graft transparency being maintained in two-thirds of them when treated with both topical and systemic steroids. Early treatment confers a benefit in terms of the recovery of graft transparency.

摘要

背景

研究穿透性角膜移植术后(PKP)严重角膜移植排斥反应后经局部和全身皮质类固醇治疗的角膜移植恢复的结果和预后因素。

方法

58 例 PKP 后严重角膜移植排斥反应患者接受局部和全身皮质类固醇治疗。分析影响移植物透明度可逆性和维持的因素。

结果

58 只眼中有 37 只(63.8%)恢复了透明性。在恢复透明性的 37 只眼中,有 25 只保持了移植物的清晰度,而其余的在平均 6.0±4.3 个月后发生了角膜失代偿。在恢复透明性的病例中,排斥反应与全身皮质类固醇治疗之间的间隔较短(OR,0.88,95%CI.0.80-0.97,P=0.0093)。角膜透明性恢复后角膜失代偿的倾向于发生在再次移植的病例中(OR,0.09,95%CI.0.01-0.54,P=0.0091)。

结论

PKP 后严重角膜移植排斥反应约有三分之二是可逆的,在接受局部和全身皮质类固醇治疗后,其中三分之二的患者保持了移植物的透明性。早期治疗有助于恢复移植物的透明度。

相似文献

2
Penetrating keratoplasty for endothelial decompensation in eyes with buphthalmos.
Cornea. 2003 Apr;22(3):198-204. doi: 10.1097/00003226-200304000-00003.
5
[Interim results from the prospective "Erlanger Non-high-risk Penetrating Keratoplasty Study" in 207 patients].
Klin Monbl Augenheilkd. 2000 Sep;217(3):163-70. doi: 10.1055/s-2000-10340.
7
[Factors Affecting Outcomes of Repeated Penetrating Keratoplasty].
Nippon Ganka Gakkai Zasshi. 2015 Sep;119(9):625-31.
8
Indications and outcome of repeat penetrating keratoplasty in India.
BMC Ophthalmol. 2005 Nov 2;5:26. doi: 10.1186/1471-2415-5-26.
9
Twelve-year follow-up of penetrating keratoplasty.
Jpn J Ophthalmol. 2017 Mar;61(2):131-136. doi: 10.1007/s10384-016-0489-2. Epub 2016 Nov 24.
10
Treatment of fungal keratitis by penetrating keratoplasty.
Br J Ophthalmol. 2001 Sep;85(9):1070-4. doi: 10.1136/bjo.85.9.1070.

引用本文的文献

2
Incidence of Complications Related to Corneal Graft in a Group of 758 Patients.
J Clin Med. 2022 Dec 28;12(1):220. doi: 10.3390/jcm12010220.
3
Impact of pandemic COVID-19 lockdown on penetrating keratoplasty patients.
Indian J Ophthalmol. 2023 Jan;71(1):95-100. doi: 10.4103/ijo.IJO_1190_22.
4
Impact of COVID-19 pandemic on patients with corneal transplant.
Indian J Ophthalmol. 2021 Jul;69(7):1967-1968. doi: 10.4103/ijo.IJO_651_21.
6
In Vivo Characteristics of Corneal Endothelium/Descemet Membrane Complex for the Diagnosis of Corneal Graft Rejection.
Am J Ophthalmol. 2017 Jun;178:27-37. doi: 10.1016/j.ajo.2017.02.026. Epub 2017 Mar 2.
7
Long-lasting corneal endothelial graft rejection successfully reversed after dexamethasone intravitreal implant.
Int Med Case Rep J. 2016 Jul 11;9:187-91. doi: 10.2147/IMCRJ.S107926. eCollection 2016.
8
Graft rejection in pediatric penetrating keratoplasty: Clinical features and outcomes.
Oman J Ophthalmol. 2015 Jan-Apr;8(1):33-7. doi: 10.4103/0974-620X.149862.

本文引用的文献

1
Efficacy and safety of long-term corticosteroid eye drops after penetrating keratoplasty: a prospective, randomized, clinical trial.
Ophthalmology. 2012 Apr;119(4):668-73. doi: 10.1016/j.ophtha.2011.10.016. Epub 2012 Jan 20.
2
Factors influencing outcomes of the treatment of allograft corneal rejection.
Am J Ophthalmol. 2011 Sep;152(3):358-363.e2. doi: 10.1016/j.ajo.2011.02.013. Epub 2011 Jun 17.
3
Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis.
Ophthalmology. 2010 Jul;117(7):1300-5.e7. doi: 10.1016/j.ophtha.2010.01.039. Epub 2010 Jun 3.
4
Corneal transplant survival after onset of severe endothelial rejection.
Ophthalmology. 2007 Sep;114(9):1630-6. doi: 10.1016/j.ophtha.2006.12.012. Epub 2007 Mar 23.
5
Risk factors for the first episode of corneal graft rejection in keratoconus.
Cornea. 2006 Oct;25(9):1005-11. doi: 10.1097/01.ico.0000240098.01468.4c.
6
Outcome of corneal transplant rejection: a 10-year study.
Clin Exp Ophthalmol. 2005 Dec;33(6):623-7. doi: 10.1111/j.1442-9071.2005.01107.x.
7
Risk factors for corneal graft failure and rejection in penetrating keratoplasty.
Acta Ophthalmol Scand. 2001 Jun;79(3):251-5. doi: 10.1034/j.1600-0420.2001.790308.x.
8
Outcome of Corneal transplantation rejection.
Cornea. 2001 May;20(4):350-3. doi: 10.1097/00003226-200105000-00002.
10
Graft failure after penetrating keratoplasty.
Surv Ophthalmol. 1990 Mar-Apr;34(5):325-56. doi: 10.1016/0039-6257(90)90110-h.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验